SEARCH

SEARCH BY CITATION

References

  • Barnard E. A., Skolnick P., Olsen R. W., Mohler H., Sieghart W., Biggio G., Braestrup C., Bateson A. N. and Langer S. Z. (1998) International Union of Pharmacology XV. Subtypes of γ-aminobutyric acidA receptors: classification on the basis of subunit structure and function. Pharmacol. Rev. 50, 291313.
  • Boileau A. J., Kucken A. M., Evers A. R. and Czajkowski C. (1998) Molecular dissection of benzodiazepine binding and allosteric coupling using chimeric γ-aminobutyric acidA receptor subunits. Mol. Pharmacol. 53, 295303.
  • Brejc K., Van Dijk W. J., Klaassen R. V., Schuurmans M., Van Der Oost J., Smit A. B. and Sixma T. K. (2001) Crystal structure of an Ach-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411, 269276.
  • Buhr A., Baur R., Malherbe P. and Sigel E. (1996) Point mutations of the α1β2γ2 γ-aminobutyric acidA receptor affecting modulation of the channel by ligands of the benzodiazepine binding site. Mol. Pharmacol. 49, 10801084.
  • Buhr A., Schaerer M. T., Baur R. and Sigel E. (1997) Residues at position 206 and 209 of the α1 subunit of γ-aminobutyric acidA receptors influence affinities for benzodiazepine site ligands. Mol. Pharmacol. 52, 676682.
  • Casula M. A., Bromidge F. A., Pillai G. V., Wingrove P. B., Martin K., Maubach K., Seabrook G. R., Whiting P. J. and Hadingham K. L. (2001) Identification of amino acid residues responsible for the α5 subunit binding selectivity of L-655,708, a benzodiazepine binding site ligand at the GABAA receptor. J. Neurochem. 77, 445451.
  • Corringer P.-J., Le Novère N. and Changeux J.-P. (2000) Nicotinic receptors at the molecular level. Annu. Rev. Pharmacol. Toxicol. 40, 431458.
  • Cromer B. A., Morton C. J. and Parker M. W. (2002) Anxiety over GABAA receptor structure relieved by AChBP. Trends Biochem. Sci. 27, 280287.
  • Davies M. and Dunn S. M. J. (1998) Identification of a unique domain in bovine brain GABAA receptors that is photoaffinity labeled by [3H]Ro15-4513. Biochem. Biophys. Res. Commun. 246, 650653.
  • Davies M., Martin I. L., Bateson A. N., Hadingham K. L., Whiting P. J. and Dunn S. M. J. (1996) Identification of domains that are photoaffinity labeled by [3H]flunitrazepam and [3H]Ro15-4513. Neuropharmacology 35, 11991208.
  • Davies M., Bateson A. N. and Dunn S. M. J. (1998) Structural requirements for ligand interactions at the benzodiazepine recognition site of the GABAA receptor. J. Neurochem. 70, 21882194.
  • Davies M., Newell J. G., Derry J. M. C., Martin I. L. and Dunn S. M. J. (2000) Characterization of the interaction of zopiclone with γ-aminobutyric acid type A receptors. Mol. Pharmacol. 58, 756762.
  • Duncalfe L. L. and Dunn S. M. J. (1996) Mapping of GABAA receptor sites that are photoaffinity-labelled by [3H]flunitrazepam and [3H]Ro15-4513. Eur. J. Pharmacol. 298, 313319.
  • Dunn S. M. J., Davies M., Muntoni A. L. and Lambert J. J. (1999) Mutagenesis of the rat alpha1 subunit of the gamma-aminobutyric acid(A) receptor reveals the importance of residue 101 in determining the allosteric effects of benzodiazepine site ligands. Mol. Pharmacol. 56, 768774.
  • Ernst M., Brauchart D., Boresch S. and Sieghart W. (2003) Comparative modeling of GABAA receptors: limits, insights, future developments. Neuroscience 119, 933943.
  • Farrar S. J., Whiting P. J., Bonnert T. P. and McKernan R. M. (1999) Stoichiometry of a ligand-gated ion channel determined by fluorescence energy transfer. J. Biol. Chem. 274, 1010010104.
  • Gunnersen D., Kaufman C. M. and Skolnick P. (1996) Pharmacological properties of recombinant ‘diazepam-insensitive’ GABAA receptors. Neuropharmacology 35, 13071314.
  • Hadingham K. L., Garrett E. M., Wafford K. A., Bain C., Heavens R. P., Sirinathsinghji D. J. S. and Whiting P. J. (1996) Cloning of cDNAs encoding the human γ-aminobutyric acid type A receptor α6 subunit and characterization of the pharmacology of α6-containing receptors. Mol. Pharmacol. 49, 253259.
  • He X., Huang Q., Ma C., Yu S., McKernan R. and Cook J. M. (2000) Pharmacophore/receptor models for GABAA/BzR α2β3γ2, α3β3γ2 and α4β3γ2 recombinant subtypes. Included volume analysis and comparison to α1β3γ2, α5β3γ2 and α6β3γ2 subtypes. Drug Des. Discov. 17, 131171.
  • Huang Q., He X., Ma C., Liu R., Yu S., Dayer C. A., Wenger G. R., McKernan R. and Cook J. M. (2000) Pharmacophore/receptor models for GABAA/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach. J. Med. Chem. 43, 7195.
  • Ito Y., Abiko E., Mitani K. and Fukuda H. (1994) Characterization of diazepam-insensitive [3H]Ro 15-4513 binding in rodent brain and cultured cerebellar neuronal cells. Neurochem. Res. 19, 289295.
  • Knoflach F., Benke D., Wang Y., Scheurer L., Lüddens H., Hamilton B. J., Carter D. B., Mohler H. and Benson J. A. (1996) Pharmacological modulation of the diazepam-insensitive recombinant γ-aminobutyric acidA receptors α4β2γ2 and α6β2γ2. Mol. Pharmacol. 50, 12531261.
  • Korpi E. R., Gründer G. and Lüddens H. (2002) Drug interactions at GABAA receptors. Prog. Neurobiol. 67, 113159.
  • Kucken A. M., Teissére J. A., Seffinga-Clark J., Wagner D. A. and Czajkowski C. (2003) Structural requirements for imidazobenzodiazepine binding to GABAA receptors. Mol. Pharmacol. 63, 289296.
  • Moore K. R. and Blakely R. D. (1994) Restriction site-independent formation of chimeras from homologous neurotransmitter–transporter cDNAs. Biotechniques 17, 130136.
  • Newell J. G., Davies M., Bateson A. N. and Dunn S. M. J. (2000) Tyrosine 62 of the gamma-aminobutyric acid type A receptor beta 2 subunit is an important determinant of high affinity agonist binding. J. Biol. Chem. 275, 1419814204.
  • Ortells M. O. and Lunt G. G. (1995) Evolutionary history of the ligand-gated ion-channel superfamily of receptors. Trends Neurosci. 18, 121127.
  • Sawyer G. W., Chiara D. C., Olsen R. W. and Cohen J. B. (2002) Identification of the bovine γ-aminobutyric acid type A receptor α subunit residues photolabeled by the imidazobenzodiazepine [3H]Ro15-4513. J. Biol. Chem. 277, 5003650045.
  • Schaerer M. T., Buhr A., Baur R. and Sigel E. (1998) Amino acid residue 200 on the α1 subunit of GABAA receptors affects the interaction with selected benzodiazepine binding site ligands. Eur. J. Pharmacol. 354, 283287.
  • Sigel E. (2002) Mapping of the benzodiazepine recognition site on GABAA receptors. Curr. Top. Med. Chem. 2, 833839.
  • Sigel E. and Buhr A. (1997) The benzodiazepine binding site of GABAA receptors. Trends Pharmacol. Sci. 18, 425429.
  • Smith G. B. and Olsen R. W. (1995) Functional domains of GABAA receptors. Trends Pharmacol. Sci. 16, 162168.
  • Tretter V., Ehya N., Fuchs K. and Sieghart W. (1997) Stoichiometry and assembly of a recombinant GABAA receptor subtype. J. Neurosci. 17, 27282737.
  • Wieland H. A., Lüddens H. and Seeburg P. H. (1992) A single histidine in GABAA receptors is essential for benzodiazepine agonist binding. J. Biol. Chem. 267, 1429.
  • Wong G., Koehler K. F., Skolnick P., Gu Z.-Q., Ananthan S., Schönholzer P., Hunkeler W., Zhang W. and Cook J. M. (1993) Synthetic and computer-assisted analysis of the structural requirements for selective, high-affinity ligand binding to the diazepam-insensitive benzodiazepine receptors. J. Med. Chem. 36, 18201830.
  • Yang W., Drewe J. A. and Lan. N. C. (1995) Cloning and characterization of the human GABAA receptor α4 subunit: identification of a unique diazepam-insensitive binding site. Eur. J. Pharmacol. 291, 319325.